A new report highlights the need to find alternatives for the treatment of osteoarthritis, a progressive, degenerative joint disease that affects a large percentage of elderly individuals.
Treatment currently centers on palliative care, including nonsteroidal anti-inflammatory drugs (NSAIDs). Because of controversy over these drugs, treatment alternatives are necessary. Also the lack of awareness of the disease calls for more research, according to Clare Churchill, healthcare senior analyst for London-based Datamonitor and author of “Stakeholder Opinions: Osteoarthritis — Preconceptions Damage Awareness and Treatments.”
The report highlights key issues in osteoarthritis therapy, including unmet needs, current treatment controversies, advancements in patient involvement and clinical trial end-points and novel therapies in the developmental pipeline.
